The company plans to use the funds to conduct an early feasibility study and a pivotal trial for its transfemoral tricuspid heart valve replacement system, Topaz.European device company TRiCares has raised $50m in a Series D financing round to develop its transfemoral tricuspid heart valve replacement system, Topaz.The company plans to use the funds to […]
